2019 - NOW
XENOHELIX Co., Ltd. has grown into a specialized biohealth company covering the entire process from the development of in vitro diagnostic medical devices to
clinical trials, regulatory approval, and mass production, based on precision molecular diagnostic technology.
2025 - NOW
26. 03
Launch of EX HEAL and miPDRN cosmetics
26. 02
Secured KRW 3 billion in strategic investment
25. 09
Launch of EX HEAL Booster
2023 - 2024
24. 11
In Vitro Diagnostic Medical Device Manufacturing Certification (Export)
24. 09
Establishment of Smart Factory
24. 07
Selected for the Bio & Medical Technology Development Program by the Ministry of Science and ICT (In Vitro Diagnostic Device for Metabolic Dysfunction-Associated Fatty Liver Disease, KRW 6 billion)
24. 06
Selected for Post TIPS Program by the Ministry of SMEs and Startups (KRW 300 million)
24. 02
In Vitro Diagnostic Medical Device Manufacturing Registration_XENOPURE gDNA Purification Kit
23. 12
Severance MD Individual Investment Association No.1 & 2: Series B Investment
23. 10
IRB Approval_XENO-Q (Parkinson’s Disease Diagnostic Product) Pivotal Clinical Trial Conducted
23. 09
KB New Deal Innovation Fund: Series B Investment
Product Supply Agreement with Taiwan Distributor
2021 - 2022
22. 12
(Minister of Science and ICT Award) Uni-Tec Demo Day
22. 09
(Ministry of Food and Drug Safety) In Vitro Diagnostic Medical Device Manufacturing License
22. 07
Selected for [2022 Free Economic Zone Innovation Ecosystem Development Project] Technology Support Program
22. 06
Selected for 2022 Biosafety Standard Research Facility Establishment Support Program
ISO 13485:2016 Certification
22. 04
Compliance Certification for Manufacturing and Quality Management Standards of In Vitro Diagnostic Medical Devices (GMP)
Selected for 2022 Multi-Ministry Full-Cycle Medical Device R&D Program (KRW 4 billion)
22. 01
Selected for 2022 BIG3 Innovation Startup Package
21. 12
(Minister of SMEs and Startups Award) D-Star Problem Solver Platform
Grand Prize, 3rd (Biohealth) Competition
21. 09
Selected as an Excellent Venture Company
21. 07
Partners No. 9 Investment Association: A Bridge Investment
Almus Growth Support Investment Association No.1: A Bridge Investment
21. 06
Industry-Academia Cooperation Agreement with Incheon Jaeneung University
21. 01
Selected for 2021 BIG3 Innovation Startup Package
2019 - 2020
20. 12
Selected for the Senior Workforce Employment Support Program
20. 09
Selected for the SME Technology Innovation Development Program
Launch of XENOPURE™
20. 06
Establishment of XENOHELIX Co., Ltd. Seoul Branch
20. 05
Selected as an Innovative Growth Company in the BIG3 Sector by the Ministry of SMEs and Startups
KB Growth Support Fund: Series A Investment
20. 03
LMO BL2 Certification
19. 12
Corporate Research Institute Certified by the Korea Industrial Technology Association
19. 11
Establishment of Songdo Branch
19. 10
Selected for TIPS (Tech Incubator Program for Startups)
Registered as a Full Member of the Korea Venture Business Association
Registered as a Research Institute Company
19. 09
Selected for U-TECH Valley Program by Korea Technology Finance Corporation
Certified as a Venture Company by Korea Technology Finance Corporation
19. 08
Selected for the Initial Startup Package by the Korea Institute of Startup & Entrepreneurship Development
19. 07
Establishment of XENOHELIX Co., Ltd., a subsidiary of Yonsei University Holdings
